Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men

The clearance concept with special reference to determination of glomerular filtration rate in patients with fluid retention

(2014) Ulrik L. Henriksen et al.   CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING

GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody

(2014) Charles Pyke et al.   ENDOCRINOLOGY

Glucagon-Like Peptide-1 (GLP-1): Effect on Kidney Hemodynamics and Renin-Angiotensin-Aldosterone System in Healthy Men

(2013) Jeppe Skov et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure

(2013) Minsuk Kim et al.   NATURE MEDICINE

Methods of assessing renal function

(2013) Guido Filler et al.   PEDIATRIC NEPHROLOGY

Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males

(2013) Jeppe Skov et al.   Endocrine Connections

Investigation of the haemodynamic effects of exenatide in healthy male subjects

(2012) Buddhike Mendis et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The effect of glucagon-like peptide 1 on cardiovascular risk

(2012) Jacob Sivertsen et al.   Nature Reviews Cardiology

Cardiovascular Effects of Glucagonlike peptide–1 Agonists

(2011) Michael H. Davidson   AMERICAN JOURNAL OF CARDIOLOGY

Effects of a long-acting GLP-1 mimetic (PF-04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus

(2011) S. M. Gustavson et al.   DIABETES OBESITY & METABOLISM

Effects of Exenatide on Systolic Blood Pressure in Subjects With Type 2 Diabetes

(2009) T. Okerson et al.   AMERICAN JOURNAL OF HYPERTENSION

Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time

(2009) B. Gallwitz et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Blood volume, blood pressure and total body sodium: internal signalling and output control

(2008) P. Bie   Acta Physiologica

Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans

(2008) Adil E. Bharucha et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

(2008) Kiwon Ban et al.   CIRCULATION